Evidence map›Paper›PMID 37875973›Full record

ArticleActa neuropathologica communications2023

Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 status.

Arnault Tauziède-Espariat, Emmanuelle Uro-Coste, Yvan Nicaise, Philipp Sievers, Andreas von Deimling, Felix Sahm, Oumaima Aboubakr, Alice Métais, Fabrice Chrétien, Pascale Varlet

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta neuropathologica communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Arnault Tauziède-EspariatDepartment of Neuropathology, GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, 1, rue Cabanis, Paris, F-75014, France. a.tauziede-espariat@ghu-paris.fr.
Emmanuelle Uro-CosteDepartment of Pathology, Toulouse University Hospital, Toulouse, France.
Yvan NicaiseINSERM U1037, Cancer Research Center of Toulouse (CRCT), Toulouse, France.
Philipp SieversDepartment of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Andreas von DeimlingDepartment of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Felix SahmDepartment of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Oumaima AboubakrDepartment of Neuropathology, GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, 1, rue Cabanis, Paris, F-75014, France.
Alice MétaisDepartment of Neuropathology, GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, 1, rue Cabanis, Paris, F-75014, France.
Fabrice ChrétienDepartment of Neuropathology, GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, 1, rue Cabanis, Paris, F-75014, France.
Pascale VarletDepartment of Neuropathology, GHU-Paris Psychiatrie et Neurosciences, Hôpital Sainte Anne, 1, rue Cabanis, Paris, F-75014, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Brain NeoplasmsGlioblastomaGliomaChildHumansInhibitor of Differentiation Protein 2Isocitrate DehydrogenaseMutationN-Myc Proto-Oncogene ProteinTumor Suppressor Protein p53ID2 protein, humanInhibitor of Differentiation Protein 2Isocitrate DehydrogenaseMYCN protein, humanN-Myc Proto-Oncogene ProteinTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID37875973
PMCPMC10594904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.